Utrecht University, Department of Clinical and Health Psychology, Utrecht, The Netherlands.
Best Pract Res Clin Rheumatol. 2012 Jun;26(3):305-19. doi: 10.1016/j.berh.2012.05.004.
The prevalence of clinical anxiety and clinical depression in rheumatic diseases is about twice the prevalence seen in the general population. At a milder level, the occurrence of psychological distress that does not fulfil diagnostic criteria of anxiety and depression is even higher. Evidence indicates that this high prevalence is multifactorial. Correlational studies suggest that possible factors for anxiety and depression include the suffering accompanying somatic symptoms, functional limitations, pro-inflammatory cytokines, helplessness due to the uncontrollable, unpredictable and progressive nature of the disease, and other factors associated with having a chronic disease. This article reviews the prevalence and diagnosis of anxiety and depression in rheumatic diseases and it examines the contents and the impact of psychological interventions to address these difficulties for patients.
在风湿性疾病中,临床焦虑和临床抑郁的患病率大约是普通人群的两倍。在轻度阶段,甚至更高比例的人群出现了不符合焦虑和抑郁诊断标准的心理困扰。有证据表明,这种高患病率是多因素的。相关性研究表明,焦虑和抑郁的可能因素包括伴随躯体症状、功能受限、促炎细胞因子、疾病的不可控、不可预测和进行性性质所导致的无助感,以及与患有慢性疾病相关的其他因素。本文综述了风湿性疾病中焦虑和抑郁的患病率和诊断,并探讨了心理干预的内容和对患者这些困难的影响。